Latest filing published 19 Mar 2022 for EastWest Bioscience Inc., €1,583.
This profile gathers the share dealings of Ciska Asriel in EastWest Bioscience Inc. We count 32 filings; the first trade dates from 19 February 2019 and the latest from 18 March 2022.
The open-market record is one-sided, with 23 purchases worth €82k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2022 alone, the filings show 1 purchase and no sales.
The median purchase comes to €2,281. No cluster: in 19 purchases, no other insider of the company bought within 30 days.
The newest entry dates from 19 March 2022: an open-market purchase of €1,583, in EastWest Bioscience Inc. The median gap between a trade and its publication by SEDI is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 32 declarations